We are monitoring the impact of COVID-19 on North America Bovine Respiratory Disease Treatment Market Get in touch with us for detailed analysis Know More
Share on

North America Bovine Respiratory Disease Treatment Market Research Report - By Type of Treatment and Country (The United States, Canada and Rest of North America) - Industry Analysis, Size, Share, Growth, Trends, Forecast (2022 to 2027)

Published: January, 2022
ID: 848
Pages: 145

North America Bovine Respiratory Disease Treatment Market Size (2022 to 2027)

The North America Bovine Respiratory Disease Treatment Market was estimated at USD 16.94 million in 2022. It is further projected to reach USD 39.25 million by 2027, growing at a CAGR of 18.3% during the forecast period. The U.S. feedlot industry estimates a huge annual loss for bovine respiratory disease (BRD) due to loss of production, increased labor expenses, pharmaceutical costs, and death deriving from BRD. 

BRD refers to any disease of the lower or upper respiratory tracts in cattle and is commonly associated with lung infections, which can cause pneumonia. Bovine Respiratory Disease is far too common, far too costly, and, for the most part, seems far too hard to handle. If cattle are treated more than once, they never get back to that peak performance.

The disease is caused by various factors such as Host factors, which include animal age, immunity, genetics, and exposure to pathogens; environmental factors involve crowding, temperature, commingling and transport, Internal or external parasite infections, and Infectious agents. The weight loss that animal has due to BRD sickness will stay with them throughout the feeding period. Hence, productivity is reduced. Antibiotics and anti-inflammatory drugs are now being used for combination treatment and are expected to improve the treatment's success rate.

This research report segmented and sub-segmented the North America Bovine Respiratory Disease Treatment Market into the following categories:

By Treatment Type: 

  • Anti-Infectious Agents
    • Antibiotics           
    • Sulfas    
  • Anti-Parasiticides                 
  • Bronchodilators                    
  • Oral Rehydration Fluids                     
  • Non-Steroidal Anti-Inflammatories               
  • Mucolytics

By Country: 

  • The United States
  • Canada
  • Rest of North America

Some of the promising companies operating in the North American Bovine Respiratory Disease Treatment Market are Zoetis Inc., Merck & Co. Inc., Bayer Corporation, Eli Lilly & Co, Merial S.A.S, Boehringer Ingelheim Vetmedica, Novartis Animal Health, Vibrac S.A., Ceva Sante Animale, and Vétoquinol S.A.

1. Introduction                                                 

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                           

                1.4 General Study Assumptions                                

2. Research Methodology                                                           

                2.1 Introduction                                              

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                            

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                     

                                2.2.4 Expert Validation                  

                2.3 Analysis Design                                         

                2.4 Study Timeline                                          

3. Overview                                                      

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 New Developments                                

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                      

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                               

5. Market Segmentation                                                              

                5.1 By Type of Treatment                                            

                                5.1.1 Anti-Infectious Agents                       

                                                5.1.1.1 Antibiotics           

                                                5.1.1.2 Sulfas    

                                5.1.2 Anti-Parasiticides                 

                                5.1.3 Bronchodilators                    

                                5.1.4 Oral Rehydration Fluids                     

                                5.1.5 Non-Steroidal Anti-Inflammatories               

                                5.1.6 Mucolytics                              

6. Geographical Analysis                                                              

                                6.1 Introduction                              

                                6.2 United States                            

                                6.3 Canada                         

7. Strategic Analysis                                                       

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                      

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services               

                                7.2.5 Competitive Rivalry within the Industry                      

8. Market Leaders' Analysis                                                        

                8.1 Zoetis Inc.                                   

                                8.1.1 Overview                

                                8.1.2 Product Analysis                   

                                8.1.3 Strategic Evaluation and Operations                            

                                8.1.4 Financial analysis                  

                                8.1.5 Legal issues                            

                                8.1.6 Recent Developments                       

                                8.1.7 SWOT analysis                       

                                8.1.8 Analyst View                          

                8.2 Merck & Co. Inc.                                       

                8.3 Bayer Corporation                                   

                8.4 Eli Lilly & Co.                                              

                8.5 Merial S.A.S                               

                8.6 Boehringer Ingelheim Vetmedica                                     

                8.7 Novartis Animal Health                                          

                8.8 Vibrac S.A                                   

                8.9 Ceva Sante Animale                                

                8.10 Vétoquinol S.A.                                      

9. Competitive Landscape                                                           

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                        

                9.3 Agreements, collaborations and Joint Ventures                                          

                9.4 New Product Launches                                          

10. Expert Opinions                                                        

                10.1 Market Outlook                                     

                10.2 Investment Opportunities                                 

Appendix                                                           

                a) List of Tables                                

                b) List of Figures                                              

  1. North America Bovine Respiratory Disease Treatment Market, By Region, From 2022 - 2027 (USD Million)
  2. North America Bovine Respiratory Disease Treatment Market, By Type of Treatment, From 2022 - 2027 (USD Million)
  3. North America Anti-Infectious Agents Market, By Region, From 2022 - 2027 (USD Million)
  4. North America Bovine Respiratory Disease Treatment Market, By Anti-Infectious Agents, From 2022 - 2027 (USD Million)
  5. North America Antibiotics Market, By Region, From 2022 - 2027 (USD Million)
  6. North America Sulfas Market, By Region, From 2022 - 2027 (USD Million)
  7. North America Anti-Parasiticides Market, By Region, From 2022 - 2027 (USD Million)
  8. North America Bronchodilators Market, By Region, From 2022 - 2027 (USD Million)
  9. North America Oral Rehydration Fluids Market, By Region, From 2022 - 2027 (USD Million)
  10. North America Non-Steroidal Anti-Inflammatories Market, By Region, From 2022 - 2027 (USD Million)
  11. North America Mucolytic Market, By Region, From 2022 - 2027 (USD Million)
  12. United States Bovine Respiratory Disease Treatment Market, By Type of Treatment, From 2022 - 2027 (USD Million)
  13. United States Bovine Respiratory Disease Treatment Market, By Anti-Infectious Agents, From 2022 - 2027 (USD Million)
  14. Canada Bovine Respiratory Disease Treatment Market, By Type of Treatment, From 2022 - 2027 (USD Million)
  15. Canada Bovine Respiratory Disease Treatment Market, By Anti-Infectious Agents, From 2022 - 2027 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

3335


pdf excel
$

3680


pdf excel powerbi
$

5520


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample